Date published: 2026-5-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

Calpinactam (CAS 1205538-83-5)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
FKI-4905
Application:
Calpinactam is an anti-mycobacterial compound
CAS Number:
1205538-83-5
Molecular Weight:
767.9
Molecular Formula:
C38H57N9O8
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Calpinactam is a synthetic compound known for its activity as a calpain inhibitor. Calpains are a family of calcium-dependent, non-lysosomal cysteine proteases involved in various cellular functions, including cell motility, cell cycle progression, and apoptosis. These enzymes play a critical role in intracellular signaling pathways, modulating the turnover and function of many regulatory proteins. As a calpain inhibitor, Calpinactam interacts with the active site of calpain, preventing its proteolytic activity. This inhibition is crucial for studies investigating the pathological processes where calpain is implicated, such as neurodegenerative diseases, ischemia, and muscle wasting disorders. By blocking calpain activity, Calpinactam helps to preserve cellular integrity and function, providing a valuable tool for research into calpain′s roles in disease and health. The development and use of Calpinactam primarily revolve around its potential to modify disease progression in conditions where excessive or unregulated activation of calpain contributes to cellular damage and dysfunction. This makes it a compound of interest not only for basic biochemical research but also for potential therapeutic applications aimed at diseases involving dysregulated protease activity.


Calpinactam (CAS 1205538-83-5) References

  1. Structure and total synthesis of fungal calpinactam, a new antimycobacterial agent.  |  Koyama, N., et al. 2010. Org Lett. 12: 432-5. PMID: 20030344
  2. Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905.  |  Koyama, N., et al. 2010. J Antibiot (Tokyo). 63: 183-6. PMID: 20186169
  3. Synthesis and antimycobacterial activity of calpinactam derivatives.  |  Nagai, K., et al. 2012. Bioorg Med Chem Lett. 22: 7739-41. PMID: 23116887
  4. Anti-tubercular peptides: A quest of future therapeutic weapon to combat tuberculosis.  |  Khusro, A., et al. 2016. Asian Pac J Trop Med. 9: 1023-1034. PMID: 27890360
  5. Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis.  |  Yagi, A., et al. 2017. J Antibiot (Tokyo). 70: 685-690. PMID: 28446822
  6. Synthesis, antimycobacterial activity and influence on mycobacterial InhA and PknB of 12-membered cyclodepsipeptides.  |  Laqua, K., et al. 2018. Bioorg Med Chem. 26: 3166-3190. PMID: 29706526
  7. A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity.  |  Yathursan, S., et al. 2019. J Pept Sci. 25: e3213. PMID: 31515916
  8. A genetic tool to express long fungal biosynthetic genes.  |  Kirchgaessner, L., et al. 2023. Fungal Biol Biotechnol. 10: 4. PMID: 36726159
  9. Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.  |  Ning, Y., et al. 2023. Protein Pept Lett. 30: 280-294. PMID: 36924097
  10. Development of a nitrogen-bound hydrophobic auxiliary: application to solid/hydrophobic-tag relay synthesis of calpinactam.  |  Nakahara, H., et al. 2023. Chem Sci. 14: 6882-6889. PMID: 37389244

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Calpinactam, 250 µg

sc-394285
250 µg
$122.00